ASX - By Stock
|
ATH |
Re:
Biomarkers for AD predementia by Masters et al
|
|
pivalde
|
5 |
855 |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
5
|
855
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Biomarkers for AD predementia by Masters et al
|
|
pivalde
|
5 |
855 |
6 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
5
|
855
|
6
|
|
ASX - By Stock
|
ATH |
Biomarkers for AD predementia by Masters et al
|
|
pivalde
|
5 |
855 |
2 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
5
|
855
|
2
|
|
ASX - By Stock
|
ATH |
Hereditary hemochromatosis as potential target for ATH434 treatment
|
|
pivalde
|
1 |
489 |
0 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
1
|
489
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
pivalde
|
16 |
3.1K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
16
|
3.1K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
pivalde
|
16 |
3.1K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
16
|
3.1K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
pivalde
|
16 |
3.1K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
16
|
3.1K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
pivalde
|
18 |
4.5K |
12 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
18
|
4.5K
|
12
|
|
ASX - By Stock
|
ATH |
Re:
Alpha-synuclein induced synucleinopathies and NBIA's
|
|
pivalde
|
10 |
3.1K |
5 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
10
|
3.1K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Stanford scientists: iron-calcium in mitochondrion as target in PD treatment
|
|
pivalde
|
10 |
4.4K |
6 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
10
|
4.4K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Stanford scientists: iron-calcium in mitochondrion as target in PD treatment
|
|
pivalde
|
10 |
4.4K |
6 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
10
|
4.4K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Alpha-synuclein induced synucleinopathies and NBIA's
|
|
pivalde
|
10 |
3.1K |
8 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
10
|
3.1K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
pivalde
|
22 |
5.7K |
10 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
22
|
5.7K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
pivalde
|
22 |
5.7K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
22
|
5.7K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Week ahead - 15th April - 19th April
|
|
pivalde
|
31 |
9.5K |
9 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
31
|
9.5K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Iron chelation to treat obesity?
|
|
pivalde
|
4 |
1.3K |
8 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
4
|
1.3K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Iron chelation to treat obesity?
|
|
pivalde
|
4 |
1.3K |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
4
|
1.3K
|
5
|
|
ASX - By Stock
|
ATH |
Iron chelation to treat obesity?
|
|
pivalde
|
4 |
1.3K |
9 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
4
|
1.3K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
pivalde
|
24 |
6.4K |
10 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
24
|
6.4K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
pivalde
|
29 |
7.9K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
29
|
7.9K
|
3
|
|
ASX - By Stock
|
ATH |
another good day in New York
|
|
pivalde
|
24 |
6.4K |
9 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
24
|
6.4K
|
9
|
|
ASX - By Stock
|
ATH |
In NY ATHE up over 15%
|
|
pivalde
|
0 |
311 |
8 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
0
|
311
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
pivalde
|
29 |
7.9K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
29
|
7.9K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
pivalde
|
29 |
7.9K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
29
|
7.9K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Lixisenatide helps a bit the progression of PD
|
|
pivalde
|
8 |
2.4K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
8
|
2.4K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Lixisenatide helps a bit the progression of PD
|
|
pivalde
|
8 |
2.4K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
8
|
2.4K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Lixisenatide helps a bit the progression of PD
|
|
pivalde
|
8 |
2.4K |
7 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
8
|
2.4K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Lixisenatide helps a bit the progression of PD
|
|
pivalde
|
8 |
2.4K |
10 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
8
|
2.4K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
Lixisenatide helps a bit the progression of PD
|
|
pivalde
|
8 |
2.4K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
8
|
2.4K
|
3
|
|
ASX - By Stock
|
ATH |
Lixisenatide helps a bit the progression of PD
|
|
pivalde
|
8 |
2.4K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
8
|
2.4K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
pivalde
|
113 |
26K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
113
|
26K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
pivalde
|
113 |
26K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
113
|
26K
|
7
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
19
|
6.2K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
19
|
6.2K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
2 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
19
|
6.2K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
5 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
19
|
6.2K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
6 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
19
|
6.2K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
4 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
19
|
6.2K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
3 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
19
|
6.2K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
pivalde
|
19 |
6.2K |
3 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
19
|
6.2K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
pivalde
|
113 |
26K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
113
|
26K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
pivalde
|
113 |
26K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
113
|
26K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
pivalde
|
113 |
26K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
113
|
26K
|
0
|
|
ASX - By Stock
|
ATH |
3 posters, enough info to be big news ???
|
|
pivalde
|
0 |
608 |
11 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
0
|
608
|
11
|
|
ASX - By Stock
|
ATH |
Re:
Claassen in AAN
|
|
pivalde
|
2 |
701 |
5 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
2
|
701
|
5
|
|
ASX - By Stock
|
ATH |
Re:
The ape study in AAN
|
|
pivalde
|
3 |
940 |
3 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
3
|
940
|
3
|
|
ASX - By Stock
|
ATH |
Re:
The ape study in AAN
|
|
pivalde
|
3 |
940 |
3 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
3
|
940
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Stamler's presentation in AAN
|
|
pivalde
|
1 |
454 |
4 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
1
|
454
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Claassen in AAN
|
|
pivalde
|
2 |
701 |
5 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
2
|
701
|
5
|
|
ASX - By Stock
|
ATH |
Claassen in AAN
|
|
pivalde
|
2 |
701 |
4 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
2
|
701
|
4
|
|